56 related articles for article (PubMed ID: 17459055)
1. Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression.
Oda Y; Ohishi Y; Basaki Y; Kobayashi H; Hirakawa T; Wake N; Ono M; Nishio K; Kuwano M; Tsuneyoshi M
Cancer Sci; 2007 Jul; 98(7):1020-6. PubMed ID: 17459055
[TBL] [Abstract][Full Text] [Related]
2. Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer.
Kang Y; Hu W; Ivan C; Dalton HJ; Miyake T; Pecot CV; Zand B; Liu T; Huang J; Jennings NB; Rupaimoole R; Taylor M; Pradeep S; Wu SY; Lu C; Wen Y; Huang J; Liu J; Sood AK
J Natl Cancer Inst; 2013 Oct; 105(19):1485-95. PubMed ID: 24062525
[TBL] [Abstract][Full Text] [Related]
3. The potential regulatory role of RNA methylation in ovarian cancer.
Zhao S; Zhang M; Zhu X; Xing J; Zhou J; Yin X
RNA Biol; 2023 Jan; 20(1):207-218. PubMed ID: 37194218
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
5. Y-box binding protein 1 augments sorafenib resistance
Liu T; Xie XL; Zhou X; Chen SX; Wang YJ; Shi LP; Chen SJ; Wang YJ; Wang SL; Zhang JN; Dou SY; Jiang XY; Cui RL; Jiang HQ
World J Gastroenterol; 2021 Jul; 27(28):4667-4686. PubMed ID: 34366628
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of tRNA-derived fragments and tRNA halves in cancer treatment resistance.
Zhang Y; Qian H; He J; Gao W
Biomark Res; 2020; 8():52. PubMed ID: 33072328
[TBL] [Abstract][Full Text] [Related]
7. Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).
Lou L; Wang J; Lv F; Wang G; Li Y; Xing L; Shen H; Zhang X
Cell Oncol (Dordr); 2021 Feb; 44(1):109-133. PubMed ID: 32894437
[TBL] [Abstract][Full Text] [Related]
8. Prevention of breast cancer by dietary polyphenols-role of cancer stem cells.
Gu HF; Mao XY; Du M
Crit Rev Food Sci Nutr; 2020; 60(5):810-825. PubMed ID: 30632783
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in homeostasis and diseases.
Chen K; Bao Z; Tang P; Gong W; Yoshimura T; Wang JM
Cell Mol Immunol; 2018 Apr; 15(4):324-334. PubMed ID: 29375126
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.
Wang W; Zheng Y; Jia J; Li C; Duan Q; Li R; Wang X; Shao Y; Chen C; Yan H
Exp Ther Med; 2017 Jul; 14(1):499-506. PubMed ID: 28672959
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.
Jia J; Zheng Y; Wang W; Shao Y; Li Z; Wang Q; Wang Y; Yan H
Mol Med Rep; 2017 Jan; 15(1):240-248. PubMed ID: 27922666
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis.
Sun S; Cai J; Yang Q; Zhu Y; Zhao S; Wang Z
PLoS One; 2016; 11(11):e0166058. PubMed ID: 27812204
[TBL] [Abstract][Full Text] [Related]
13. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges.
Vela M; Aris M; Llorente M; Garcia-Sanz JA; Kremer L
Front Immunol; 2015; 6():12. PubMed ID: 25688243
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 over-expression and survival in cancer: a system review and meta-analysis.
Zhao H; Guo L; Zhao H; Zhao J; Weng H; Zhao B
Oncotarget; 2015 Mar; 6(7):5022-40. PubMed ID: 25669980
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4.
Kashima K; Watanabe M; Sato Y; Hata J; Ishii N; Aoki Y
Cancer Sci; 2014 Oct; 105(10):1343-50. PubMed ID: 25154453
[TBL] [Abstract][Full Text] [Related]
16. Intracellular trafficking and endocytosis of CXCR4 in fetal mesenchymal stem/stromal cells.
Pelekanos RA; Ting MJ; Sardesai VS; Ryan JM; Lim YC; Chan JK; Fisk NM
BMC Cell Biol; 2014 May; 15():15. PubMed ID: 24885150
[TBL] [Abstract][Full Text] [Related]
17. The role of the PTEN/PI3K/Akt pathway on prognosis in epithelial ovarian cancer: a meta-analysis.
Cai J; Xu L; Tang H; Yang Q; Yi X; Fang Y; Zhu Y; Wang Z
Oncologist; 2014 May; 19(5):528-35. PubMed ID: 24718516
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of CXCR4 in ovarian cancer: a meta-analysis.
Liu CF; Liu SY; Min XY; Ji YY; Wang N; Liu D; Ma N; Li ZF; Li K
PLoS One; 2014; 9(3):e92629. PubMed ID: 24658065
[TBL] [Abstract][Full Text] [Related]
19. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
Mantwill K; Naumann U; Seznec J; Girbinger V; Lage H; Surowiak P; Beier D; Mittelbronn M; Schlegel J; Holm PS
J Transl Med; 2013 Sep; 11():216. PubMed ID: 24044901
[TBL] [Abstract][Full Text] [Related]
20. Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis.
Tsofack SP; Meunier L; Sanchez L; Madore J; Provencher D; Mes-Masson AM; Lebel M
BMC Cancer; 2013 Jun; 13():303. PubMed ID: 23800275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
